Angelalign Technology (FRA:77D) Piotroski F-Score: 6 (As of Jul. 08, 2026) — Near Median


FRA:77D Angelalign Technology Inc FRA:77D
69 GF Score
Price €8.15
GF Value €11.62
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Angelalign Technology Piotroski F-Score?

Angelalign Technology FRA:77D 69 Piotroski F-Score is 6 as of Jul. 08, 2026, which is at its 10-year median of 6.00. GuruFocus rates FRA:77D with a GF Score™ of 69/100 and a GF Value™ of €11.62 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 807 Medical Devices & Instruments companies, Angelalign Technology ranks better than 81.16% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Angelalign Technology has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Angelalign Technology's Piotroski F-Score or its related term are showing as below:

FRA:77D' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 6   Max: 8
Current: 6

During the past 8 years, the highest Piotroski F-Score of Angelalign Technology was 8. The lowest was 3. And the median was 6.

Angelalign Technology  (FRA:77D) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Angelalign Technology Piotroski F-Score Related Terms


Angelalign Technology Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Angelalign Technology's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Angelalign Technology Piotroski F-Score Chart

Angelalign Technology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial 7.00 3.00 6.00 6.00 6.00

Angelalign Technology Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 0.00 6.00 0.00 6.00

FRA:77D vs ISRG, BDX, MDLN: Piotroski F-Score Comparison

For the Medical Instruments & Supplies subindustry, Angelalign Technology's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Angelalign Technology Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Angelalign Technology's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Angelalign Technology's Piotroski F-Score falls into.


FRA:77D
69GF Score
Angelalign Technology Inc FRA:77D
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Net Income was €24.3 Mil.
Cash Flow from Operations was €67.1 Mil.
Revenue was €316.2 Mil.
Gross Profit was €198.9 Mil.
Average Total Assets from the begining of this year (Dec24)
to the end of this year (Dec25) was (647.596 + 652.836) / 2 = €650.216 Mil.
Total Assets at the begining of this year (Dec24) was €647.6 Mil.
Long-Term Debt & Capital Lease Obligation was €8.0 Mil.
Total Current Assets was €427.7 Mil.
Total Current Liabilities was €143.6 Mil.
Net Income was €11.6 Mil.

Revenue was €256.7 Mil.
Gross Profit was €160.7 Mil.
Average Total Assets from the begining of last year (Dec23)
to the end of last year (Dec24) was (615.858 + 647.596) / 2 = €631.727 Mil.
Total Assets at the begining of last year (Dec23) was €615.9 Mil.
Long-Term Debt & Capital Lease Obligation was €7.1 Mil.
Total Current Assets was €469.5 Mil.
Total Current Liabilities was €122.3 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Angelalign Technology's current Net Income (TTM) was 24.3. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Angelalign Technology's current Cash Flow from Operations (TTM) was 67.1. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec24)
=24.285/647.596
=0.03750023

ROA (Last Year)=Net Income/Total Assets (Dec23)
=11.569/615.858
=0.01878517

Angelalign Technology's return on assets of this year was 0.03750023. Angelalign Technology's return on assets of last year was 0.01878517. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Angelalign Technology's current Net Income (TTM) was 24.3. Angelalign Technology's current Cash Flow from Operations (TTM) was 67.1. ==> 67.1 > 24.3 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec24 to Dec25
=8.048/650.216
=0.01237743

Gearing (Last Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=7.112/631.727
=0.01125803

Angelalign Technology's gearing of this year was 0.01237743. Angelalign Technology's gearing of last year was 0.01125803. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec25)=Total Current Assets/Total Current Liabilities
=427.706/143.578
=2.97891042

Current Ratio (Last Year: Dec24)=Total Current Assets/Total Current Liabilities
=469.547/122.329
=3.83839482

Angelalign Technology's current ratio of this year was 2.97891042. Angelalign Technology's current ratio of last year was 3.83839482. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Angelalign Technology's number of shares in issue this year was 169.95. Angelalign Technology's number of shares in issue last year was 169.043. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=198.887/316.22
=0.62895136

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=160.658/256.692
=0.62587848

Angelalign Technology's gross margin of this year was 0.62895136. Angelalign Technology's gross margin of last year was 0.62587848. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec24)
=316.22/647.596
=0.48829826

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec23)
=256.692/615.858
=0.41680387

Angelalign Technology's asset turnover of this year was 0.48829826. Angelalign Technology's asset turnover of last year was 0.41680387. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+0+0+0+1+1
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Angelalign Technology has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 6 mean?
Angelalign Technology (FRA:77D) has a Piotroski F-Score of 6 as of Jul. 08, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Angelalign Technology and its competitors. This is near median its historical median of 6.00. Over the past decade, Angelalign Technology's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Angelalign Technology ranks #152 out of 807 companies in the Medical Devices & Instruments industry, placing it in the top 18.8%.
Is Angelalign Technology's Piotroski F-Score too high?
Angelalign Technology's current Piotroski F-Score of 6 is near median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Angelalign Technology's value of 6 is 20% above this industry median. Based on the distribution chart, Angelalign Technology ranks #152 out of 807 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Angelalign Technology has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Angelalign Technology's Piotroski F-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Angelalign Technology ranks #152 out of 807 companies for Piotroski F-Score. This places Angelalign Technology in the top 19% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Angelalign Technology's value of 6 is 20% above this benchmark. Historically, Angelalign Technology's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Angelalign Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 807 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Angelalign Technology's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Angelalign Technology and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Angelalign Technology's current Piotroski F-Score is 6, which is near median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Angelalign Technology stock overvalued right now?
Based on GuruFocus' analysis, Angelalign Technology (FRA:77D) is currently considered Significantly Undervalued. The stock's GF Value™ is €11.62, compared to a current price of €8.15 — trading 29.9% below its estimated fair value. The current Piotroski F-Score is 6, which is near median its 10-year median of 6.00 and 20% above the Medical Devices & Instruments industry median of 5.00. Angelalign Technology's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Angelalign Technology (FRA:77D), the current Piotroski F-Score is 6 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Angelalign Technology (FRA:77D) Overvalued in 2026?

Based on GuruFocus' analysis, Angelalign Technology stock appears to be undervalued. The current stock price of €8.15 is trading 29.9% below its estimated GF Value™ of €11.62. GuruFocus considers Angelalign Technology to be Significantly Undervalued.

Key valuation signals for FRA:77D:

  • Piotroski F-Score: 6 (near median its 10-year median of 6.00)
  • GF Value™: €11.62 vs. price of €8.15 (29.9% below fair value)
  • GF Score™: 69/100 with 4 warning signs
  • Industry Position: 20% above the Medical Devices & Instruments median (#152 of 807)

No single metric tells the full story. See the FRA:77D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Angelalign Technology Business Description

Other Exchanges AGLFF:USA06699:Hong Kong
Address No. 500 Zhengli Road, 6th Floor - 7th Floor, Building No. 7, KIC Business Center, Yangpu District, Shanghai, CHN
Angelalign Technology Inc is an investment holding company. It is principally engaged in clear aligner treatment solutions, including treatment planning services, manufacturing, and marketing of clear aligners. The company provides dental professionals with self-developed digital orthodontic solutions. The company's Angelalign clear aligner system facilitates dental professionals throughout the entire clear aligner treatment process, including digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, and helps dental professionals design, review, and modify treatment plans.
69GF Score

Get the complete analysis for FRA:77D

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.15
Price
€11.62
GF Value